Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma
Figure 5.Drug sensitivity analysis to drugs of high- and low-risk subgroups. Differential chemotherapeutic responses in high- and low-risk patients (A–X).